These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 14704943
1. Echographic follow-up of malignant melanoma of the choroid after brachytherapy with 106Ru. Novak-Andrejcic K, Jancar B, Hawlina M. Klin Monbl Augenheilkd; 2003 Dec; 220(12):853-60. PubMed ID: 14704943 [Abstract] [Full Text] [Related]
2. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma. Isager P, Ehlers N, Urbak SF, Overgaard J. Acta Oncol; 2006 Dec; 45(3):285-93. PubMed ID: 16644571 [Abstract] [Full Text] [Related]
3. Echographic evaluation of choroidal melanomas treated with ruthenium-106 plaques: the treatment failures. Perri P, Police G, Pastena B, Ravalli L, Grande L, Rossi A. Ophthalmologica; 1998 Dec; 212 Suppl 1():33-6. PubMed ID: 9730745 [Abstract] [Full Text] [Related]
4. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation. Anteby I, Axer-Siegel R, Pe'er J. Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070 [Abstract] [Full Text] [Related]
5. [Prospective nonrandomised analysis of "Sandwich Therapy" for malignant melanoma of the choroid]. Stoffelns BM, Kutzner J, Schöpfer K, Frising M. Klin Monbl Augenheilkd; 2002 Apr; 219(4):211-5. PubMed ID: 12022003 [Abstract] [Full Text] [Related]
6. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone. Yarovoy AA, Magaramov DA, Bulgakova ES. Brachytherapy; 2012 Apr; 11(3):224-9. PubMed ID: 22104351 [Abstract] [Full Text] [Related]
7. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma. Marconi DG, de Castro DG, Rebouças LM, Bernardes Gil GO, Fogaroli RC, Conte Maia MA, Gobo Silva ML, Assis Pellizzon AC, Motono Chojniak MM. Brachytherapy; 2013 Apr; 12(3):235-9. PubMed ID: 22436517 [Abstract] [Full Text] [Related]
8. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD. Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155 [Abstract] [Full Text] [Related]
13. Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications. Kreusel KM, Bechrakis N, Riese J, Krause L, Wachtlin J, Foerster MH. Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1575-80. PubMed ID: 16738857 [Abstract] [Full Text] [Related]
14. Echographic follow up of malignant melanoma of the choroid after brachytherapy with iodine-125. Abraham-Marín M, Cortes-Luna C, Morales-Cantón V, Velasco-Barona C, Moragrega-Adame E. Acta Clin Croat; 2012 Dec; 51 Suppl 1():79-81. PubMed ID: 23431728 [Abstract] [Full Text] [Related]
16. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm. Filì M, Trocme E, Bergman L, See TRO, André H, Bartuma K, Girnita L, All-Eriksson C, Seregard S, Stålhammar G. Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871 [Abstract] [Full Text] [Related]